David Patience Med Tech Acquisition Corp (MTACW) insider trading activity

MTACW Quotes by TradingView

David Patience is Chief Financial Officer of MedTech Acquisition Corp. Currently has a direct ownership of 265,000 shares of MTACW, which is worth approximately $58,300. The most recent transaction as insider was on Nov 24, 2025, when has been sold 65,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
32.5% 3M change
n/a 12M change
Total Value Held $58,300

David Patience Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2025
BUY
Grant, award, or other acquisition
-
65,000 Added 19.7%
265,000 Common Stock
Aug 14 2025
BUY
Grant, award, or other acquisition
-
200,000 Added 50.0%
200,000 Common Stock

Also insider at

AXDX
Accelerate Diagnostics, Inc Healthcare
Chief Financial Officer
DP

David Patience

Chief Financial Officer
Tucson, AZ

Track Institutional and Insider Activities on MTACW

Follow MedTech Acquisition Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MTACW shares.

Notify only if

Insider Trading

Get notified when an Med Tech Acquisition Corp insider buys or sells MTACW shares.

Notify only if

News

Receive news related to MedTech Acquisition Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MTACW